442 related articles for article (PubMed ID: 12545260)
1. Serum- and CSF-concentrations of brain specific proteins in hydrocephalus.
Beems T; Simons KS; Van Geel WJ; De Reus HP; Vos PE; Verbeek MM
Acta Neurochir (Wien); 2003 Jan; 145(1):37-43. PubMed ID: 12545260
[TBL] [Abstract][Full Text] [Related]
2. Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase.
Honda M; Tsuruta R; Kaneko T; Kasaoka S; Yagi T; Todani M; Fujita M; Izumi T; Maekawa T
J Trauma; 2010 Jul; 69(1):104-9. PubMed ID: 20093985
[TBL] [Abstract][Full Text] [Related]
3. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
Takano R; Misu T; Takahashi T; Sato S; Fujihara K; Itoyama Y
Neurology; 2010 Jul; 75(3):208-16. PubMed ID: 20644148
[TBL] [Abstract][Full Text] [Related]
4. Neuron-specific enolase and myelin basic protein: relationship of cerebrospinal fluid concentrations to the neurologic condition of asphyxiated full-term infants.
Garcia-Alix A; Cabañas F; Pellicer A; Hernanz A; Stiris TA; Quero J
Pediatrics; 1994 Feb; 93(2):234-40. PubMed ID: 7510064
[TBL] [Abstract][Full Text] [Related]
5. Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children.
Berger RP; Adelson PD; Pierce MC; Dulani T; Cassidy LD; Kochanek PM
J Neurosurg; 2005 Jul; 103(1 Suppl):61-8. PubMed ID: 16122007
[TBL] [Abstract][Full Text] [Related]
6. Identification of inflicted traumatic brain injury in well-appearing infants using serum and cerebrospinal markers: a possible screening tool.
Berger RP; Dulani T; Adelson PD; Leventhal JM; Richichi R; Kochanek PM
Pediatrics; 2006 Feb; 117(2):325-32. PubMed ID: 16452350
[TBL] [Abstract][Full Text] [Related]
7. [Cerebrospinal fluid level of aldolase C in patients with various neurological disorders: comparison with neuron-specific enolase, S-100b protein and creatine kinase BB isoenzyme].
Murayama T; Matsuoka Y; Takahashi A; Kato K; Yanagi T
Rinsho Shinkeigaku; 1989 May; 29(5):568-73. PubMed ID: 2791404
[TBL] [Abstract][Full Text] [Related]
8. Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury.
Böhmer AE; Oses JP; Schmidt AP; Perón CS; Krebs CL; Oppitz PP; D'Avila TT; Souza DO; Portela LV; Stefani MA
Neurosurgery; 2011 Jun; 68(6):1624-30; discussion 1630-1. PubMed ID: 21368691
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of NSE and S100B from serum and cerebrospinal fluid in patients with spontaneous subarachnoid hemorrhage.
Moritz S; Warnat J; Bele S; Graf BM; Woertgen C
J Neurosurg Anesthesiol; 2010 Jan; 22(1):21-31. PubMed ID: 20027011
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of cerebrospinal fluid neuron-specific enolase and S-100b protein in Guillain-Barré syndrome.
Mokuno K; Kiyosawa K; Sugimura K; Yasuda T; Riku S; Murayama T; Yanagi T; Takahashi A; Kato K
Acta Neurol Scand; 1994 Jan; 89(1):27-30. PubMed ID: 8178624
[TBL] [Abstract][Full Text] [Related]
11. [Role of neuron specific enolase and S100 protein in evaluation of brain damage in patients resuscitated from cardiac arrest].
Miao WL; Li HL; Wang HD; Wang J; Liu H; Ren HX; Lin HY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Dec; 19(12):749-52. PubMed ID: 18093437
[TBL] [Abstract][Full Text] [Related]
12. Sequential analyses of neurobiochemical markers of cerebral damage in cerebrospinal fluid and serum in CNS infections.
Lins H; Wallesch CW; Wunderlich MT
Acta Neurol Scand; 2005 Nov; 112(5):303-8. PubMed ID: 16218912
[TBL] [Abstract][Full Text] [Related]
13. Neurochemical markers of brain damage in cerebrospinal fluid during induction treatment of acute lymphoblastic leukemia in children.
Osterlundh G; Kjellmer I; Lannering B; Rosengren L; Nilsson UA; Márky I
Pediatr Blood Cancer; 2008 Apr; 50(4):793-8. PubMed ID: 17973312
[TBL] [Abstract][Full Text] [Related]
14. Determination of glial fibrillary acidic protein, S100, myelin basic protein and neuron specific enolase in cerebrospinal fluid from patients suffering from dementia.
Vermuyten K
Acta Neurol Belg; 1989; 89(3-4):318. PubMed ID: 2483491
[No Abstract] [Full Text] [Related]
15. Glial fibrillary acidic protein and protein S-100B: different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer's disease and Creutzfeldt-Jakob disease.
Jesse S; Steinacker P; Cepek L; von Arnim CA; Tumani H; Lehnert S; Kretzschmar HA; Baier M; Otto M
J Alzheimers Dis; 2009; 17(3):541-51. PubMed ID: 19433893
[TBL] [Abstract][Full Text] [Related]
16. [Cerebrospinal fluid neuron-specific enolase (NSE) and S-100b protein in Guillain-Barré syndrome--their relations to prognosis].
Mokuno K; Yasuda T; Sugimura K; Riku S; Takahashi A; Kato K
Rinsho Shinkeigaku; 1992 May; 32(5):535-7. PubMed ID: 1458733
[TBL] [Abstract][Full Text] [Related]
17. Serum concentration of NSE and S-100b during LVAD in non-resuscitated patients.
Pfeifer R; Ferrari M; Börner A; Deufel T; Figulla HR
Resuscitation; 2008 Oct; 79(1):46-53. PubMed ID: 18617311
[TBL] [Abstract][Full Text] [Related]
18. [Serum S-100B protein and neuron-specific enolase after traumatic brain injury].
Sawauchi S; Taya K; Murakami S; Ishi T; Ohtsuka T; Kato N; Kaku S; Tanaka T; Morooka S; Yuhki K; Urashima M; Abe T
No Shinkei Geka; 2005 Nov; 33(11):1073-80. PubMed ID: 16277220
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of S-100B protein and neuron-specific enolase in glioma patients: a pilot study.
Vos MJ; Postma TJ; Martens F; Uitdehaag BM; Blankenstein MA; Vandertop WP; Slotman BJ; Heimans JJ
Anticancer Res; 2004; 24(4):2511-4. PubMed ID: 15330206
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of glial fibrillary acidic protein correlate to tumour volume of high-grade gliomas.
Brommeland T; Rosengren L; Fridlund S; Hennig R; Isaksen V
Acta Neurol Scand; 2007 Dec; 116(6):380-4. PubMed ID: 17986096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
